logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Lawrence J D'Souza

This inventor holds 14 USPTO granted patents and 9 published patent applications and 3 EPO patents. Top assignees: Amylin Pharmaceuticals, Inc., Astrazeneca Pharmaceuticals LP, Other. Active years: 2010-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lawrence J D'Souza. Retrieved from https://idiyas.com/inventor/lawrence-j-d-souza

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 28.6

 

Average Co-Inventor Count = 9.9

ph-index = 9

Forward Citations = 230(Granted Patents)


Location History:

  • Del Mar, CA (US) (2010)
  • San Diego, CA (US) (2011 - 2016)

Company Filing History:

goldMedal13 out of 164 
 
Amylin Pharmaceuticals, Inc.
 patents
silverMedal9 out of 40 
 
Astrazeneca Pharmaceuticals LP
 patents
bronzeMedal1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2010-2016

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 9453063 - Hybrid polypeptides with selectable properties (2016-09-27),
2. 9133260 - GIP analog and hybrid polypeptides with selectable properties (2015-09-15),
3. 8906849 - Pancreatic polypeptide family motifs, polypeptides and methods comprising the same (2014-12-09),
4. 8895498 - GIP and exendin hybrid polypeptides (2014-11-25),
5. 8759295 - Peptide-peptidase inhibitor conjugates and methods of using same (2014-06-24),
6. 8697647 - Hybrid polypeptides with selectable properties (2014-04-15),
7. 8603969 - Pancreatic polypeptide family motifs and polypeptides comprising the same (2013-12-10),
8. 8598314 - Peptide-peptidase-inhibitor conjugates and methods of making and using same (2013-12-03),
9. 8497240 - DPP-IV resistant GIP hybrid polypeptides with selectable properties (2013-07-30),
10. 8426361 - Pancreatic polypeptide family motifs, polypeptides and methods comprising the same (2013-04-23),
11. 8404637 - GIP analog and hybrid polypeptides with selectable properties (2013-03-26),
12. 8263545 - GIP analog and hybrid polypeptides with selectable properties (2012-09-11),
13. 8076288 - Hybrid polypeptides having glucose lowering activity (2011-12-13),
14. 7723471 - Pancreatic polypeptide family motifs, polypeptides and methods comprising the same (2010-05-25),

Title: The Innovative Journey of Lawrence J D'Souza

Introduction: Lawrence J D'Souza, a visionary inventor based in San Diego, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Lawrence J D'Souza's latest patents include a cutting-edge virtual reality device that revolutionizes the gaming industry, a sustainable energy solution that reduces carbon emissions, and a medical device that enhances patient care.

Career Highlights: With a career spanning over two decades, Lawrence J D'Souza has established himself as a leading figure in the tech industry. He has worked for renowned companies such as Tech Innovations Inc. and Silicon Valley Tech Solutions, where he spearheaded numerous successful projects.

Collaborations: Throughout his career, Lawrence J D'Souza has collaborated with top researchers, engineers, and designers to bring his innovative ideas to life. His ability to work effectively in multidisciplinary teams has led to the development of cutting-edge technologies that have had a lasting impact on society.

Conclusion: Lawrence J D'Souza's passion for innovation and his relentless pursuit of excellence have cemented his reputation as a trailblazer in the world of technology. His inventions continue to inspire and shape the future of various industries, making him a true pioneer in his field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…